Introduction
============

Chronic kidney disease (CKD) is a worldwide problem that is in need of particular attention. The prevalence of CKD varies with age[@b1-cia-7-409] and is markedly high in those of the population greater than 64 years old.[@b2-cia-7-409],[@b3-cia-7-409] In China, the population of those over 60 years old will increase by 16.55% every year; by 2040 this age group will account for 28% of the entire population, which means that China will be considered an ageing society.[@b4-cia-7-409] These findings highlight the clinical and public health importance of CKD. The glomerular filtration rate (GFR) is typically considered to be the best way to assess renal function in healthy or diseased states. Direct measurement of GFR by inulin clearance is often impractical. Radioisotopic methods using ethylenediaminetetraacetic acid (51Cr EDTA), 125 iodine iothalamate, and so on provide acceptable alternatives to inulin clearance.[@b5-cia-7-409] However, these methods are cumbersome, expensive, and are available to only a few hospitals. Many formulae using serum creatinine (SC) have been established to estimate GFR in adults. The National Kidney Foundation has recommended that the Cockroft--Gault (CG) equation and the Modification of Diet in Renal Disease (MDRD) equations should be used to estimate GFR in adults.[@b6-cia-7-409] However, the SC-based equations were not initially developed for elderly people. Additionally, older individuals have decreased lean body mass and often suffer from chronic diseases associated with decreased muscle mass and SC levels,[@b7-cia-7-409] thus, when applied to elderly people, the effectiveness of such equations is doubtful.

As previously described,[@b8-cia-7-409] GFR estimation equations showed a great deal of bias in elderly Chinese CKD patients. In this study, we increased the sample size and again evaluated the accuracy of various GFR estimation equations in elderly Chinese patients with CKD, comparing them with radionuclide GFRs in a clinical setting.

Research design and methods
===========================

The present study was conducted among 319 elderly Chinese CKD patients (121 women; mean ± SD age 70.0 ± 6.8 years; standard GFR (sGFR) measured by ^99m^Tc-DTPA GFR was 39.4 ± 21.8 mL/min per 1.73 m^2^) from January 2005 through December 2009 at the Third Affiliated Hospital of Sun Yet-sun University, China. The patient exclusion criteria were as previously described.[@b8-cia-7-409] None of the subjects were undergoing dialysis during the study period. The CKD patients were assigned to one of five stages based on the National Kidney Foundation (NKF) Kidney Disease Outcomes Quality Initiative (K/DOQI) clinical practice guidelines.[@b9-cia-7-409] The causes and stages of CKD, as well as other details, are listed in [Table 1](#t1-cia-7-409){ref-type="table"}. For convenience, stages 1 and 2, and stages 4 and 5 were combined. The study was approved by the institutional review board at the Third Affiliated Hospital of Sun Yet-sun University. All patients provided informed consent before participating in the study.

Glomerular filtration rate, measured by the ^99m^Tc-DTPA renal dynamic imaging method and standardized by body surface area (BSA), was used as the sGFR.[@b10-cia-7-409]--[@b12-cia-7-409] ^99m^Tc-DTPA renal dynamic imaging (modified Gate's method) was measured by Millennium TMMPR SPECT using the General Electric Medical System. ^99m^Tc-DTPA renal imaging showed good agreement with plasma clearance of 51Cr EDTA.[@b13-cia-7-409] The ^99m^Tc-DTPA renal dynamic imaging method used was as previously described.[@b8-cia-7-409] After image acquisition, the patient's weight and height were entered into the eNTEGRA Workstation (General Electric Company, Waukesha, WI), on which all imaging data were recorded. The sGFR was automatically calculated, according to Gate's algorithm.

Estimations of renal function
-----------------------------
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The results of the CG equation, the Jelliffe-1973 equation, and the Hull equation were standardized for a BSA[@b20-cia-7-409] of 1.73 m^2^.

Other measurements
------------------

A single serum determination was performed on the same day prior to measurement of GFR using ^99m^Tc-DTPA renal dynamic imaging. The SC levels, serum albumin, and urea were assayed on a Hitachi 7180 autoanalyzer (Hitachi, Tokyo, Japan) with reagents from Roche Diagnostics (Mannheim, Germany). Serum creatinine was determined by the enzymatic method. Sex, age, height, and weight were simultaneously recorded.

Statistical analysis
--------------------

The sGFR and the estimated GFR (eGFR) were compared using Bland--Altman analysis. The precision was measured as the width between the 95% limits of agreement. A prior acceptable tolerance for the difference between eGFR and sGFR was defined as twice the limit for CKD stages, which is 60 mL/min/1.73 m^2^.[@b8-cia-7-409] The accuracy of GFR estimates was determined as the percentage of results deviating less than 15%, 30%, and 50% from the sGFR. The sensitivity and specificity of all the equations in correctly classified CKD stage 3 (GFR \< 60 mL/min/1.73 m^2^) were based upon the cut points established by the National Kidney Foundation[@b9-cia-7-409] and were calculated and compared according to the receiver operating characteristic (ROC) curve approach. In the preliminary analysis,[@b8-cia-7-409] the Jelliffe-1973 equation performed better than the other equations. Therefore, we chose eGFR measured by the Jelliffe-1973 equation as the reference against which all comparisons between equations were made. Results were considered to be significant at *P* \< 0.05. All statistical analyses were performed using SPSS software (version 11.0; IBM, Armonk, NY) and Medcalc for Windows (version 9.3.9.0; Medcalc Software, Mariekerke, Belgium).

Results
=======

Overall performance of the equations
------------------------------------

The medians of difference of the four-variable MDRD equation and the six-variable MDRD equation were less than those of the other equations. The interquartile range (IQR) of difference for the CG equation and the Hull equation were smaller. The accuracies with a deviation less than 15% from the sGFR of the Hull equation and the CG equation were higher. The CG equation and the Jelliffe-1973 equation provided better results than the others in accuracies with deviations less than 30% and 50% from the sGFR. However, none of the equations had accuracies that reached 70% while differing less than 30% from the sGFR. Chronic kidney disease stage misclassifications by the four-variable MDRD equation and the Jelliffe-1973 equation were less than that of the other equations. All of the equations had CKD stage misclassification higher than 42% ([Table 2](#t2-cia-7-409){ref-type="table"}). We used Bland--Altman plot (see [Figure 1](#f1-cia-7-409){ref-type="fig"}) analysis to calculate the mean of the difference between eGFR and sGFR and the precision of eGFR. Using this approach, the CKD-EPI equation and the Jelliffe-1973 equation demonstrated less means of the difference than the other equations. The precisions of the GFR estimated by the CG equation and the CKD-EPI equation were better than the other equations. However, the agreement limits of the equations, except for the CG equation, exceeded the prior acceptable tolerances, defined as 60 mL/min/1.73 m^2^. The ROC curve analysis showed that the maximum diagnostic accuracy of all the equations for the diagnosis of moderate renal failure (GFR \< 60 mL/min/1.73 m^2^) was not statistically significant (*P* \> 0.05 compared with the Jelliffe-1973 GFR). Detailed performances are listed in [Tables 2](#t2-cia-7-409){ref-type="table"} and [3](#t3-cia-7-409){ref-type="table"}, and [Figure 2](#f2-cia-7-409){ref-type="fig"}.

Performance of various stages of CKD
------------------------------------

In CKD stages 1 and 2, the median of the difference of the Jelliffe-1973 equation was smaller. The IQR of difference for the CKD-EPI equation was smaller. The CKD-EPI equation provided better results than the others in accuracies with deviations less than 15%, 30%, and 50% from the sGFR. In CKD stage 3, the median of the difference of the six-variable MDRD equation was smaller. The IQR of difference for the CG equation was smaller. Accuracy with a deviation less than 15% from the sGFR of the Hull equation was higher. The CG equation provided better results than the others in accuracies with deviations less than 30% and 50% from the sGFR. In CKD stages 4 and 5, the median of the difference for the Jelliffe-1973 equation was smaller. The IQRs of difference for the CG equation and the Jelliffe-1973 equation were smaller. The Jelliffe-1973 equation revealed higher accuracies with deviation less than 15%, 30%, and 50% from the sGFR ([Table 4](#t4-cia-7-409){ref-type="table"}).

Discussion
==========

A report from the Dialysis and Transplantation Registration Group of the Chinese Society of Nephrology revealed that in 1999, the population undergoing maintenance dialysis numbered 41,755.[@b21-cia-7-409] Liu and his colleagues found that, in China, about 14.82% of the 13,383 hospitalized patients investigated were diagnosed as having CKD.[@b22-cia-7-409] They also found that the prevalence of CKD increases dramatically in older people. Therefore, in the elderly population, the evaluation of renal function is critically important in clinical practice, since it has a great impact on diagnosis and medical treatment requiring adjustment in drug dosages in the elderly. The changes in renal function that accompany aging present a decrease in GFR -- more than 1 mL/min/1.73 m^2^/year in those over the age of 40 years.[@b23-cia-7-409] However, this change can vary. Gault and Cockcroft[@b24-cia-7-409] found that the variability of creatinine clearance also increased with increasing age. This was accordant with a recent report from the Baltimore Longitudinal Study of Aging, which demonstrated that variability, such as decrease, increase, or no change, in creatinine clearance emerged in 254 healthy individuals followed up for as long as 23 years.[@b23-cia-7-409] This variability causes additional difficulties in the estimation of GFR. The American Diabetes Association recommended estimation of GFR using prediction equations based on SC determinations.[@b25-cia-7-409] However, this has still not been validated in elderly populations.

Application of SC-based GFR prediction equations to elderly patients with CKD is limited. Bevc et al[@b26-cia-7-409] found that both the MDRD equations and the CKD-EPI equation lacked precision, and the accuracy within 30% of estimated 51Cr EDTA clearance values differs according to the stage of CKD. Burkhardt et al[@b27-cia-7-409] demonstrated that the accuracies and precisions of the CG equation and the MDRD equations were low, and that there was an underestimation of actual GFR. A cross-sectional study in a French hospital with mostly Caucasian patients[@b28-cia-7-409] also found that the CG equation seemed to be the most accurate and appropriate formula. The present study revealed that none of the equations had acceptable accuracy to exactly predict GFR in an elderly population. A new equation is still needed to provide a more accurate estimation of GFR in elderly patients.

Age and body mass are important sources of bias in the prediction. All the equations in our study are based on the SC value. The generation of creatinine is determined primarily by muscle mass and dietary intake. Muscle mass is considered a constant part of total body weight. However, elderly people often have decreased lean body mass and suffer from many chronic diseases associated with decreased muscle mass and SC levels.[@b7-cia-7-409] Additionally, elderly patients are often malnourished and Compan et al found that patients classified as malnourished account for 25% of the hospitalized elderly.[@b29-cia-7-409] Older and malnourished patients are particularly at risk of having decreased GFR even with normal SC levels.[@b30-cia-7-409],[@b31-cia-7-409] All of these factors could influence the accuracy of application of the equations. Recent research finds that applying the CG equation corrected by BSA may be more precise than the MDRD equations in patients with malnutrition or inflammation. In the present study, the CG equation had higher accuracy than the other equations; however, it still did not provide acceptable accuracy.

In these prediction equations, the subjects enrolled did not adequately represent subjects older than 70 years of age. The MDRD equation had not been initially validated in older people, and the mean age was 50.6 ± 12.7 years.[@b16-cia-7-409] The CG equation was originally established with 249 patients aged 18 to 92 years. Among the patients, only 59 (23%) were over the age of 70 years and women accounted for only 4% of the patients,[@b14-cia-7-409] yet when a study was applied in an elderly population to calculate creatinine clearance, most of the subjects were female. A correction factor of 0.85 was proposed for females, according to data from earlier studies, but in Cockcroft and Gault's own study, data on females were extremely limited, so this figure must be considered pure speculation.[@b32-cia-7-409] Special attention must be given to the application of equations extended to populations not represented in the original study.

The large percentage of diabetic patients in the present study is also a source of bias. Related investigations found that many of the diabetic patients had a supernormal GFR before the onset of overt clinical diabetic nephropathy and progressive renal insufficiency.[@b33-cia-7-409],[@b34-cia-7-409] A surrogate marker based on SC cannot effectively detect emerging hyperfiltration in the early phase of diabetic nephropathies.[@b27-cia-7-409] In our study, diabetic patients make up 35.7% of the patients, so the remarkable underestimation of actual GFR by formula estimators is, in part, on account of an undetectable hyperfiltration in patients with diabetes; this is consistent with previous results.[@b35-cia-7-409],[@b36-cia-7-409] Considering the number of elderly patients with diabetes, it is understandable that our results underestimated the actual GFRs.

The methods used to measure SC were different in each study. In the original MDRD study, SC was measured by the CX3 Beckman method.[@b15-cia-7-409],[@b16-cia-7-409] In the CKD-EPI equation,[@b17-cia-7-409] SC was determined by the enzymatic method. The other equations in our study were published long ago, and the methods used for SC measurement have not been available until now.[@b36-cia-7-409] In our study, SC was measured using the enzymatic method, different from that in the MDRD study. Several studies have proven that calibration of SC assays can influence the accuracy of MDRD.[@b37-cia-7-409],[@b38-cia-7-409] Variability among clinical laboratories in the calibration of SC assays results in bias in the estimation of GFR.

In conclusion, our data indicated that when SC was measured by the enzymatic method, none of the equations considered were suitable for use in the elderly Chinese population invested in our study. Further improved formulae are needed to assess GFR in elderly Chinese CKD patients. At present, based on both overall performance and performance in different CKD stages, the CG equation may be the most accurate for use in elderly Chinese patients with CKD.
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![Bland--Altman plot of eGFR and sGFR (mL/min/1.73 m^2^). Solid line represents the mean of difference between methods; dashed lines represent 95% limits of agreement of the mean of difference between methods. (**A**--**F**) Represent for the GFR results estimated using Cockcroft--Gault equation, six-variable MDRD equation, four-variable MDRD equation, CKD-EPI equation, Jelliffe-1973 equation, and Hull equation, respectively.\
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![**R**eceiver operating characteristic curves of eGFR for the diagnosis of moderate renal failure (GFR \< 60 mL/min/1.73 m^2^).\
**Notes:** Cockcroft--Gault, MDRD6, MDRD4, CKDEPI, Jelliffe-1973, and Hull represent the results of GFR estimated by Cockcroft--Gault equation, six-variable MDRD equation, four-variable MDRD equation, CKD-EPI equation, Jelliffe-1973 equation, and Hull equation, respectively.\
**Abbreviations:** CKD-EPI, Chronic Kidney Disease Epidemiology Collaboration; eGFR, estimated glomerular filtration rate; sGFR, standard glomerular filtration rate; MDRD, Modification of Diet in Renal Disease.](cia-7-409f2){#f2-cia-7-409}

###### 

Patient characteristics

  ------------------------------------- --------------------------
  CKD cause                             
   Diabetic nephropathy                 114 (35.7)
   Hypertension                         74 (23.2)
   Chronic tubulointerstitial disease   53 (16.6)
   Primary glomerular disease           36 (11.3)
   Renovascular disease                 22 (6.9)
   Other causes or causes unknown       20 (6.3)
  Age (year)                            70.0 ± 6.8 (60--93)
  Male/female (%)                       62.1/37.9
  Weight (kg)                           61.4 ± 11.5 (30--98)
  Height (cm)                           162.0 ± 8.1 (142--184)
  BSA (m^2^)                            1.65 ± 0.17 (1.15--2.18)
  SC (umol/L)                           245.0 ± 210.2 (32--1833)
  DTPA-GFR (mL/min/1.73 m^2^)           39.4 ± 21.8 (5.7--116.6)
  ------------------------------------- --------------------------

**Note:** Results are expressed as mean ± SD (range) or n (%).

**Abbreviations:** BSA, body surface area; SC, serum creatinine; DTPA-GFR, technetium- 99m diethylenetriaminepentaacetic acid-glomerular filtration rate.

###### 

Overall performances of eGFR and sGFR

                                Precision   Difference   Accuracy within   CKD stage misclassification                        
  ----------------------------- ----------- ------------ ----------------- ----------------------------- ------ ------ ------ ------
  Cockcroft--Gault equation     58.5        −3.0         −4.3              13.9                          31.3   57.7   81.5   43.9
  Six-variable MDRD equation    69.2        1.0          −1.2              16.0                          29.5   53.6   76.5   44.2
  Four-variable MDRD equation   73.4        2.4          −0.3              17.6                          27.9   54.5   74.9   42.9
  CKD-EPI equation              62.4        −0.6         −1.9              16.7                          27.6   54.9   75.5   44.2
  Jelliffe-1973 equation        76.4        0.8          −1.8              15.1                          30.1   57.1   81.2   43.6
  Hull equation                 64.2        −1.9         −3.9              14.6                          32.9   55.2   79.3   43.9

**Abbreviation:** IQR, interquartile range.

###### 

AUCs, sensitivity, and specificity of eGFR for the diagnosis of moderate renal failure (GFR \< 60 mL/min/1.73 m^2^)

                                AUC             Sensitivity   Specificity
  ----------------------------- --------------- ------------- -------------
  Cockcroft--Gault equation     0.903 ± 0.019   0.593         0.917
  Six-variable MDRD equation    0.909 ± 0.018   0.815         0.868
  Four-variable MDRD equation   0.906 ± 0.019   0.796         0.872
  CKD-EPI equation              0.908 ± 0.019   0.778         0.883
  Jelliffe-1973 equation        0.919 ± 0.017   0.630         0.925
  Hull equation                 0.904 ± 0.019   0.667         0.917

**Note:** *P* \< 0.05 comparing with Jelliffe-1973-GFR.

**Abbreviations:** AUC, area under the receiver operating characteristic curve; eGFR, estmated glomerular filtration rate.

###### 

Performances of eGFR and sGFR in the different stages of CKD

                                Difference   Accuracy within                 
  ----------------------------- ------------ ----------------- ------ ------ ------
  **Stage 1--2**                                                             
  Cockcroft--Gault equation     −10.8        29.1              35.2   70.4   92.6
  Six-variable MDRD equation    5.9          29.5              42.6   66.7   87.0
  Four-variable MDRD equation   6.6          33.0              38.9   61.1   83.3
  CKD-EPI equation              2.2          23.9              50.0   74.1   94.4
  Jelliffe-1973 equation        0.0          44.3              24.1   64.8   79.6
  Hull equation                 −6.2         30.4              33.3   68.5   90.7
  **Stage 3**                                                                
  Cockcroft--Gault equation     −3.8         16.9              37.8   62.9   83.9
  Six-variable MDRD equation    −0.4         22.7              30.1   56.6   78.3
  Four-variable MDRD equation   3.8          22.3              29.4   60.1   76.9
  CKD-EPI equation              1.3          21.1              28.7   58.7   76.2
  Jelliffe-1973 equation        −2.2         20.2              34.3   58.7   86.7
  Hull equation                 −3.3         18.2              38.5   61.5   81.8
  **Stage 4--5**                                                             
  Cockcroft--Gault equation     −2.8         9.7               22.1   45.9   73.8
  Six-variable MDRD equation    −2.4         11.0              23.0   44.3   69.7
  Four-variable MDRD equation   −2.6         10.9              21.3   45.1   68.9
  CKD-EPI equation              −4.2         11.2              16.4   41.8   66.4
  Jelliffe-1973 equation        −1.8         9.7               27.9   51.6   75.4
  Hull equation                 −4.1         10.2              26.2   41.8   71.3

**Abbreviations:** IQR, interquartile range; eGFR, estimated glomerular filtration rate; sGFR, standard glomerular filtration rate.
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